Archive - February 2022
Sajid Javid takes nationwide healthcare road trip
WHO issues prequalification for Roche’s Actemra/RoActemra for severe or critical COVID-19
FDA accepts Priority Review for Dupixent in children with moderate-to-severe atopic dermatitis
Driven by Purpose: The Payal Sahni Story
Two cases of ‘eye bleeding’ Lassa fever found in UK
New adventure: PharmaVentures moves to London for growth strategy boost
Merck and Ridgeback fulfil US deal for molnupiravir
HCA launches first CPD standards framework for healthcare professionals